{
    "code": "01024652",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01024652",
    "time": "2019-08-23 03:11:11",
    "許可證字號": "衛署藥製字第024652號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/05\/25",
    "發證日期": "71\/01\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102465202",
    "中文品名": "&quot;華盛頓&quot;普克錠（那普洛先）",
    "英文品名": "PROX TABLETS &quot;W.P.&quot; (NAPROXEN)",
    "適應症": "骨關節炎、風濕性關節炎、僵硬性脊椎炎之消炎、解熱、鎮痛",
    "劑型": "110錠劑",
    "包裝": "100,200, 500,1000粒瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "NAPROXEN",
    "主製造廠": {
        "申請商名稱": "1202801200  華盛頓製藥廠股份有限公司",
        "申請商地址": "高雄市仁武區仁武里工業二路12號",
        "主製造廠": "",
        "製造廠名稱": "1202822300  華盛頓製藥廠股份有限公司"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808402000",
            "成分名稱": "NAPROXEN",
            "含量描述": "250",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "普克錠說明書-106-06-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01024652&Seq=001&Type=9"
        },
        {
            "title": "普克錠標籤-106-06-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01024652&Seq=001&Type=8"
        }
    ]
}